(Q26786623)

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

Mayela Rodríguez-Violante

1 June 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Humberto Calderón-Fajardo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Amin Cervantes-Arriaga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Rodrigo Llorens-Arenas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ángel Ruiz-Chow

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

Arquivos de Neuro-Psiquiatria

1 June 2020

language of work or name

English

0 references

publication date

October 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

856-860

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

Parkinson's disease: the quintessential neuropsychiatric disorder

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

The neuropsychiatry of Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Bifrontal ECT for drug-induced psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Letter to the editor: successful use of electroconvulsive therapy for refractory anxiety in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Temporary interruption of deep brain stimulation for Parkinson's disease during outpatient electroconvulsive therapy for major depression: a novel treatment strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Efficacy of ECT in severe obsessive-compulsive disorder with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

ECT for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Electroconvulsive therapy in movement disorders: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Neurotransmitters and electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Neuropsychiatric effects of Parkinson's disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20150131

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1590/0004-282X20150131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json

release_br6jtq34yrbmvmj3qe74owxv2y

1 June 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26331387%20AND%20SRC:MED&resulttype=core&format=json